APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Cancer Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Therapeutic Cancer Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025191 pages

Choose your research edition.

Industry ResearchTherapeutic Cancer Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Cancer Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Therapeutic Cancer Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Cancer Vaccines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Cancer Vaccines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Therapeutic Cancer Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Therapeutic Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Therapeutic Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Therapeutic Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Therapeutic Cancer Vaccines include Merck, GlaxoSmithKline, Bayer, VAXIMM, Northwest Biotherapeutics, Moderna, Mayo Clinic, Avax Technologies and Asterias Biotherapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Therapeutic Cancer Vaccines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Therapeutic Cancer Vaccines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Therapeutic Cancer Vaccines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Therapeutic Cancer Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Therapeutic Cancer Vaccines Segment by Company

Merck

GlaxoSmithKline

Bayer

VAXIMM

Northwest Biotherapeutics

Moderna

Mayo Clinic

Avax Technologies

Asterias Biotherapeutics

Antigenics

Therapeutic Cancer Vaccines Segment by Type

Non-specific and Cytokine Strategies

Antigen Vaccine

Whole Cell Vaccine

Others

Therapeutic Cancer Vaccines Segment by Application

Breast Cancer

Prostate Cancer

Brain Tumors

Cervical Cancer

Lung Cancer

Bladder Cancer

Others

Therapeutic Cancer Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Cancer Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Cancer Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Cancer Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Therapeutic Cancer Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Therapeutic Cancer Vaccines industry.

Chapter 3: Detailed analysis of Therapeutic Cancer Vaccines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Cancer Vaccinesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Cancer Vaccines Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Non-specific and Cytokine Strategies Table 3. Key Players of Antigen Vaccine Table 4. Key Players of Whole Cell Vaccine Table 3. Key Players of Others Table 4. Global Therapeutic Cancer Vaccines Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Breast Cancer Table 6. Key Players of Prostate Cancer Table 7. Key Players of Brain Tumors Table 8. Key Players of Cervical Cancer Table 9. Key Players of Lung Cancer Table 10. Key Players of Bladder Cancer Table 11. Key Players of Others Table 12. Global Therapeutic Cancer Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Therapeutic Cancer Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Therapeutic Cancer Vaccines Market Share by Region (2021-2026) Table 15. Global Therapeutic Cancer Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Therapeutic Cancer Vaccines Market Share by Region (2027-2032) Table 17. Therapeutic Cancer Vaccines Industry Trends Table 18. Therapeutic Cancer Vaccines Industry Drivers Table 19. Therapeutic Cancer Vaccines Industry Opportunities and Challenges Table 20. Therapeutic Cancer Vaccines Industry Restraints Table 21. Global Therapeutic Cancer Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 22. Global Therapeutic Cancer Vaccines Revenue Market Share by Company (2021-2026) Table 23. Global Therapeutic Cancer Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global Therapeutic Cancer Vaccines Key Company Head Office and Area Served Table 25. Global Therapeutic Cancer Vaccines Company, Product Type & Application Table 26. Global Therapeutic Cancer Vaccines Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global Therapeutic Cancer Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global Therapeutic Cancer Vaccines Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Therapeutic Cancer Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 31. Global Therapeutic Cancer Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 32. Global Therapeutic Cancer Vaccines Revenue Market Share by Type (2021-2026) Table 33. Global Therapeutic Cancer Vaccines Revenue Market Share by Type (2027-2032) Table 34. Global Therapeutic Cancer Vaccines Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Therapeutic Cancer Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 36. Global Therapeutic Cancer Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 37. Global Therapeutic Cancer Vaccines Revenue Market Share by Application (2021-2026) Table 38. Global Therapeutic Cancer Vaccines Revenue Market Share by Application (2027-2032) Table 39. Merck Company Information Table 40. Merck Business Overview Table 41. Merck Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Merck Therapeutic Cancer Vaccines Product Portfolio Table 43. Merck Recent Development Table 44. GlaxoSmithKline Company Information Table 45. GlaxoSmithKline Business Overview Table 46. GlaxoSmithKline Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. GlaxoSmithKline Therapeutic Cancer Vaccines Product Portfolio Table 48. GlaxoSmithKline Recent Development Table 49. Bayer Company Information Table 50. Bayer Business Overview Table 51. Bayer Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Bayer Therapeutic Cancer Vaccines Product Portfolio Table 53. Bayer Recent Development Table 54. VAXIMM Company Information Table 55. VAXIMM Business Overview Table 56. VAXIMM Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. VAXIMM Therapeutic Cancer Vaccines Product Portfolio Table 58. VAXIMM Recent Development Table 59. Northwest Biotherapeutics Company Information Table 60. Northwest Biotherapeutics Business Overview Table 61. Northwest Biotherapeutics Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Northwest Biotherapeutics Therapeutic Cancer Vaccines Product Portfolio Table 63. Northwest Biotherapeutics Recent Development Table 64. Moderna Company Information Table 65. Moderna Business Overview Table 66. Moderna Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Moderna Therapeutic Cancer Vaccines Product Portfolio Table 68. Moderna Recent Development Table 69. Mayo Clinic Company Information Table 70. Mayo Clinic Business Overview Table 71. Mayo Clinic Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Mayo Clinic Therapeutic Cancer Vaccines Product Portfolio Table 73. Mayo Clinic Recent Development Table 74. Avax Technologies Company Information Table 75. Avax Technologies Business Overview Table 76. Avax Technologies Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Avax Technologies Therapeutic Cancer Vaccines Product Portfolio Table 78. Avax Technologies Recent Development Table 79. Asterias Biotherapeutics Company Information Table 80. Asterias Biotherapeutics Business Overview Table 81. Asterias Biotherapeutics Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Asterias Biotherapeutics Therapeutic Cancer Vaccines Product Portfolio Table 83. Asterias Biotherapeutics Recent Development Table 84. Antigenics Company Information Table 85. Antigenics Business Overview Table 86. Antigenics Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Antigenics Therapeutic Cancer Vaccines Product Portfolio Table 88. Antigenics Recent Development Table 89. North America Therapeutic Cancer Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 90. North America Therapeutic Cancer Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 91. North America Therapeutic Cancer Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 92. North America Therapeutic Cancer Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 93. North America Therapeutic Cancer Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Therapeutic Cancer Vaccines Market Size by Country (2021-2026) Table 95. North America Therapeutic Cancer Vaccines Market Size by Country (2027-2032) Table 96. Europe Therapeutic Cancer Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 97. Europe Therapeutic Cancer Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 98. Europe Therapeutic Cancer Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 99. Europe Therapeutic Cancer Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 100. Europe Therapeutic Cancer Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Therapeutic Cancer Vaccines Market Size by Country (2021-2026) Table 102. Europe Therapeutic Cancer Vaccines Market Size by Country (2027-2032) Table 103. China Therapeutic Cancer Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 104. China Therapeutic Cancer Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 105. China Therapeutic Cancer Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 106. China Therapeutic Cancer Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Therapeutic Cancer Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 108. Asia Therapeutic Cancer Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 109. Asia Therapeutic Cancer Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 110. Asia Therapeutic Cancer Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 111. Asia Therapeutic Cancer Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Therapeutic Cancer Vaccines Market Size by Country (2021-2026) Table 113. Asia Therapeutic Cancer Vaccines Market Size by Country (2027-2032) Table 114. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Country (2021-2026) Table 120. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Country (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Therapeutic Cancer Vaccines Product Image Figure 2. Global Therapeutic Cancer Vaccines Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Therapeutic Cancer Vaccines Market Share by Type: 2025 VS 2032 Figure 4. Non-specific and Cytokine Strategies Image Figure 5. Antigen Vaccine Image Figure 6. Whole Cell Vaccine Image Figure 7. Others Image Figure 8. Global Therapeutic Cancer Vaccines Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Therapeutic Cancer Vaccines Market Share by Application: 2025 VS 2032 Figure 10. Breast Cancer Image Figure 11. Prostate Cancer Image Figure 12. Brain Tumors Image Figure 13. Cervical Cancer Image Figure 14. Lung Cancer Image Figure 15. Bladder Cancer Image Figure 16. Others Image Figure 17. Global Therapeutic Cancer Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 19. Global Therapeutic Cancer Vaccines Market Share by Region: 2025 VS 2032 Figure 20. Years Considered Figure 21. Global Therapeutic Cancer Vaccines Market Share by Players in 2025 Figure 22. Global Top 5 and 10 Therapeutic Cancer Vaccines Players Market Share by Revenue in 2025 Figure 23. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Therapeutic Cancer Vaccines Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Therapeutic Cancer Vaccines Revenue Market Share by Type (2021-2032) Figure 26. Global Therapeutic Cancer Vaccines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Therapeutic Cancer Vaccines Revenue Market Share by Application (2021-2032) Figure 28. North America Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 29. North America Therapeutic Cancer Vaccines Market Share by Type (2021-2032) Figure 30. North America Therapeutic Cancer Vaccines Market Share by Application (2021-2032) Figure 31. North America Therapeutic Cancer Vaccines Market Share by Country (2021-2032) Figure 32. United States Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 33. Canada Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 34. Mexico Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 35. Europe Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 36. Europe Therapeutic Cancer Vaccines Market Share by Type (2021-2032) Figure 37. Europe Therapeutic Cancer Vaccines Market Share by Application (2021-2032) Figure 38. Europe Therapeutic Cancer Vaccines Market Share by Country (2021-2032) Figure 39. Germany Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 40. France Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 41. U.K. Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 42. Italy Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 43. Russia Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 44. Nordic Countries Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 45. China Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 46. China Therapeutic Cancer Vaccines Market Share by Type (2021-2032) Figure 47. China Therapeutic Cancer Vaccines Market Share by Application (2021-2032) Figure 48. Asia Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 49. Asia Therapeutic Cancer Vaccines Market Share by Type (2021-2032) Figure 50. Asia Therapeutic Cancer Vaccines Market Share by Application (2021-2032) Figure 51. Asia Therapeutic Cancer Vaccines Market Share by Country (2021-2032) Figure 52. Japan Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 53. South Korea Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 54. Taiwan Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 55. Southeast Asia Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 56. India Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 57. Australia Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Share by Type (2021-2032) Figure 60. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Share by Application (2021-2032) Figure 61. South America, Middle East & Africa Therapeutic Cancer Vaccines Market Share by Country (2021-2032) Figure 62. Brazil Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 63. South Africa Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 64. Saudi Arabia Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 65. Turkey Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 66. Argentina Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 67. UAE Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 68. Egypt Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 69. Chile Therapeutic Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Non-specific and Cytokine Strategies
  • Antigen Vaccine
  • Whole Cell Vaccine
  • Others
Applications
  • Breast Cancer
  • Prostate Cancer
  • Brain Tumors
  • Cervical Cancer
  • Lung Cancer
  • Bladder Cancer
  • Others
Companies covered
  • Merck
  • GlaxoSmithKline
  • Bayer
  • VAXIMM
  • Northwest Biotherapeutics
  • Moderna
  • Mayo Clinic
  • Avax Technologies
  • Asterias Biotherapeutics
  • Antigenics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Therapeutic Cancer Vaccines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Non-specific and Cytokine Strategies
  5. 1.2.3 Antigen Vaccine
  6. 1.2.4 Whole Cell Vaccine
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Therapeutic Cancer Vaccines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Breast Cancer
  11. 1.3.3 Prostate Cancer
  12. 1.3.4 Brain Tumors
  13. 1.3.5 Cervical Cancer
  14. 1.3.6 Lung Cancer
  15. 1.3.7 Bladder Cancer
  16. 1.3.8 Others
  17. 1.4 Global Market Growth Prospects
  18. 1.5 Global Therapeutic Cancer Vaccines Growth Trends by Region
  19. 1.5.1 Global Therapeutic Cancer Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  20. 1.5.2 Therapeutic Cancer Vaccines Market Size by Region (2021-2026)
  21. 1.5.3 Therapeutic Cancer Vaccines Market Size by Region (2027-2032)
  22. 1.6 Assumptions and Limitations
  23. 1.7 Study Goals and Objectives
  24. 1.8 Years Considered
2 Global Therapeutic Cancer Vaccines Market Dynamics
  1. 2.1 Therapeutic Cancer Vaccines Industry Trends
  2. 2.2 Therapeutic Cancer Vaccines Industry Drivers
  3. 2.3 Therapeutic Cancer Vaccines Industry Opportunities and Challenges
  4. 2.4 Therapeutic Cancer Vaccines Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Therapeutic Cancer Vaccines Revenue by Company (2021-2026)
  2. 3.2 Global Therapeutic Cancer Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Therapeutic Cancer Vaccines Key Company Head office and Area Served
  4. 3.4 Global Therapeutic Cancer Vaccines Company, Product Type & Application
  5. 3.5 Global Therapeutic Cancer Vaccines Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Therapeutic Cancer Vaccines Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Therapeutic Cancer Vaccines Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Therapeutic Cancer Vaccines Tier 1, Tier 2, and Tier 3
4 Therapeutic Cancer Vaccines Market by Type
  1. 4.1 Global Therapeutic Cancer Vaccines Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Therapeutic Cancer Vaccines Market Size by Type (2021-2032)
  3. 4.3 Global Therapeutic Cancer Vaccines Market Size Share by Type (2021-2032)
5 Therapeutic Cancer Vaccines Market by Application
  1. 5.1 Global Therapeutic Cancer Vaccines Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Therapeutic Cancer Vaccines Market Size by Application (2021-2032)
  3. 5.3 Global Therapeutic Cancer Vaccines Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck Therapeutic Cancer Vaccines Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 GlaxoSmithKline Therapeutic Cancer Vaccines Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bayer Therapeutic Cancer Vaccines Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 VAXIMM
  20. 6.4.1 VAXIMM Company Information
  21. 6.4.2 VAXIMM Business Overview
  22. 6.4.3 VAXIMM Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 VAXIMM Therapeutic Cancer Vaccines Product Portfolio
  24. 6.4.5 VAXIMM Recent Developments
  25. 6.5 Northwest Biotherapeutics
  26. 6.5.1 Northwest Biotherapeutics Company Information
  27. 6.5.2 Northwest Biotherapeutics Business Overview
  28. 6.5.3 Northwest Biotherapeutics Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Northwest Biotherapeutics Therapeutic Cancer Vaccines Product Portfolio
  30. 6.5.5 Northwest Biotherapeutics Recent Developments
  31. 6.6 Moderna
  32. 6.6.1 Moderna Company Information
  33. 6.6.2 Moderna Business Overview
  34. 6.6.3 Moderna Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Moderna Therapeutic Cancer Vaccines Product Portfolio
  36. 6.6.5 Moderna Recent Developments
  37. 6.7 Mayo Clinic
  38. 6.7.1 Mayo Clinic Company Information
  39. 6.7.2 Mayo Clinic Business Overview
  40. 6.7.3 Mayo Clinic Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Mayo Clinic Therapeutic Cancer Vaccines Product Portfolio
  42. 6.7.5 Mayo Clinic Recent Developments
  43. 6.8 Avax Technologies
  44. 6.8.1 Avax Technologies Company Information
  45. 6.8.2 Avax Technologies Business Overview
  46. 6.8.3 Avax Technologies Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Avax Technologies Therapeutic Cancer Vaccines Product Portfolio
  48. 6.8.5 Avax Technologies Recent Developments
  49. 6.9 Asterias Biotherapeutics
  50. 6.9.1 Asterias Biotherapeutics Company Information
  51. 6.9.2 Asterias Biotherapeutics Business Overview
  52. 6.9.3 Asterias Biotherapeutics Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Asterias Biotherapeutics Therapeutic Cancer Vaccines Product Portfolio
  54. 6.9.5 Asterias Biotherapeutics Recent Developments
  55. 6.10 Antigenics
  56. 6.10.1 Antigenics Company Information
  57. 6.10.2 Antigenics Business Overview
  58. 6.10.3 Antigenics Therapeutic Cancer Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Antigenics Therapeutic Cancer Vaccines Product Portfolio
  60. 6.10.5 Antigenics Recent Developments
7 North America
  1. 7.1 North America Therapeutic Cancer Vaccines Market Size (2021-2032)
  2. 7.2 North America Therapeutic Cancer Vaccines Market Size by Type
  3. 7.2.1 North America Therapeutic Cancer Vaccines Market Size by Type (2021-2026)
  4. 7.2.2 North America Therapeutic Cancer Vaccines Market Size by Type (2027-2032)
  5. 7.2.3 North America Therapeutic Cancer Vaccines Market Share by Type (2021-2032)
  6. 7.3 North America Therapeutic Cancer Vaccines Market Size by Application
  7. 7.3.1 North America Therapeutic Cancer Vaccines Market Size by Application (2021-2026)
  8. 7.3.2 North America Therapeutic Cancer Vaccines Market Size by Application (2027-2032)
  9. 7.3.3 North America Therapeutic Cancer Vaccines Market Share by Application (2021-2032)
  10. 7.4 North America Therapeutic Cancer Vaccines Market Size by Country
  11. 7.4.1 North America Therapeutic Cancer Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Therapeutic Cancer Vaccines Market Size by Country (2021-2026)
  13. 7.4.3 North America Therapeutic Cancer Vaccines Market Size by Country (2027-2032)
  14. 7.4.4 North America Therapeutic Cancer Vaccines Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Therapeutic Cancer Vaccines Market Size (2021-2032)
  2. 8.2 Europe Therapeutic Cancer Vaccines Market Size by Type
  3. 8.2.1 Europe Therapeutic Cancer Vaccines Market Size by Type (2021-2026)
  4. 8.2.2 Europe Therapeutic Cancer Vaccines Market Size by Type (2027-2032)
  5. 8.2.3 Europe Therapeutic Cancer Vaccines Market Share by Type (2021-2032)
  6. 8.3 Europe Therapeutic Cancer Vaccines Market Size by Application
  7. 8.3.1 Europe Therapeutic Cancer Vaccines Market Size by Application (2021-2026)
  8. 8.3.2 Europe Therapeutic Cancer Vaccines Market Size by Application (2027-2032)
  9. 8.3.3 Europe Therapeutic Cancer Vaccines Market Share by Application (2021-2032)
  10. 8.4 Europe Therapeutic Cancer Vaccines Market Size by Country
  11. 8.4.1 Europe Therapeutic Cancer Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Therapeutic Cancer Vaccines Market Size by Country (2021-2026)
  13. 8.4.3 Europe Therapeutic Cancer Vaccines Market Size by Country (2027-2032)
  14. 8.4.4 Europe Therapeutic Cancer Vaccines Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Therapeutic Cancer Vaccines Market Size (2021-2032)
  2. 9.2 China Therapeutic Cancer Vaccines Market Size by Type
  3. 9.2.1 China Therapeutic Cancer Vaccines Market Size by Type (2021-2026)
  4. 9.2.2 China Therapeutic Cancer Vaccines Market Size by Type (2027-2032)
  5. 9.2.3 China Therapeutic Cancer Vaccines Market Share by Type (2021-2032)
  6. 9.3 China Therapeutic Cancer Vaccines Market Size by Application
  7. 9.3.1 China Therapeutic Cancer Vaccines Market Size by Application (2021-2026)
  8. 9.3.2 China Therapeutic Cancer Vaccines Market Size by Application (2027-2032)
  9. 9.3.3 China Therapeutic Cancer Vaccines Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Therapeutic Cancer Vaccines Market Size (2021-2032)
  2. 10.2 Asia Therapeutic Cancer Vaccines Market Size by Type
  3. 10.2.1 Asia Therapeutic Cancer Vaccines Market Size by Type (2021-2026)
  4. 10.2.2 Asia Therapeutic Cancer Vaccines Market Size by Type (2027-2032)
  5. 10.2.3 Asia Therapeutic Cancer Vaccines Market Share by Type (2021-2032)
  6. 10.3 Asia Therapeutic Cancer Vaccines Market Size by Application
  7. 10.3.1 Asia Therapeutic Cancer Vaccines Market Size by Application (2021-2026)
  8. 10.3.2 Asia Therapeutic Cancer Vaccines Market Size by Application (2027-2032)
  9. 10.3.3 Asia Therapeutic Cancer Vaccines Market Share by Application (2021-2032)
  10. 10.4 Asia Therapeutic Cancer Vaccines Market Size by Country
  11. 10.4.1 Asia Therapeutic Cancer Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Therapeutic Cancer Vaccines Market Size by Country (2021-2026)
  13. 10.4.3 Asia Therapeutic Cancer Vaccines Market Size by Country (2027-2032)
  14. 10.4.4 Asia Therapeutic Cancer Vaccines Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Therapeutic Cancer Vaccines Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst